CASIA OpenIR  > 中国科学院分子影像重点实验室
GX1-conjugated poly(lactic acid) nanoparticles encapsulating Endostar for improved in vivo anticolorectal cancer treatment
Du, Yang1; Zhang, Qian1; Jing, Lijia2; Liang, Xiaolong2; Chi, Chongwei1; Li, Yaqian1; Yang, Xin1; Dai, Zhifei2; Tian, Jie1
2015
发表期刊INTERNATIONAL JOURNAL OF NANOMEDICINE
卷号10页码:3791-3802
文章类型Article
摘要Tumor angiogenesis plays a key role in tumor growth and metastasis; thus, targeting tumor-associated angiogenesis is an important goal in cancer therapy. However, the efficient delivery of drugs to tumors remains a key issue in antiangiogenesis therapy. GX1, a peptide identified by phage-display technology, is a novel tumor vasculature endothelium-specific ligand and possesses great potential as a targeted vector and antiangiogenic agent in the diagnosis and treatment of human cancers. Endostar, a novel recombinant human endostatin, has been shown to inhibit tumor angiogenesis. In this study, we developed a theranostic agent composed of GX1-conjugated poly(lactic acid) nanoparticles encapsulating Endostar (GPENs) and labeled with the near-infrared dye IRDye 800CW to improve colorectal tumor targeting and treatment efficacy in vivo. The in vivo fluorescence molecular imaging data showed that GPENs (IRDye 800CW) more specifically targeted tumors than free IRDye 800CW in colorectal tumor-bearing mice. Moreover, the antitumor efficacy was evaluated by bioluminescence imaging and immunohistology, revealing that GPENs possessed improved antitumor efficacy on subcutaneous colorectal xenografts compared to other treatment groups. Thus, our study showed that GPENs, a novel GX1 peptide guided form of nanoscale Endostar, can be used as a theranostic agent to facilitate more efficient targeted therapy and enable real-time monitoring of therapeutic efficacy in vivo.
关键词Gx1 Peptide Endostar Colorectal Cancer Angiogenesis Irdye 800cw Molecular Imaging
WOS标题词Science & Technology ; Life Sciences & Biomedicine
关键词[WOS]RECOMBINANT HUMAN ENDOSTATIN ; GASTRIC-CANCER ; INTEGRIN ALPHA(V)BETA(3) ; ANTIANGIOGENIC THERAPY ; TUMOR ANGIOGENESIS ; TARGETED THERAPY ; DRUG-DELIVERY ; VASCULATURE ; ACTIVATION ; RESISTANCE
收录类别SCI
语种英语
WOS研究方向Science & Technology - Other Topics ; Pharmacology & Pharmacy
WOS类目Nanoscience & Nanotechnology ; Pharmacology & Pharmacy
WOS记录号WOS:000355177500001
引用统计
被引频次:13[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.ia.ac.cn/handle/173211/7927
专题中国科学院分子影像重点实验室
作者单位1.Chinese Acad Sci, Inst Automat, State Key Lab Management & Control Complex, Key Lab Mol Imaging, Beijing 100190, Peoples R China
2.Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Du, Yang,Zhang, Qian,Jing, Lijia,et al. GX1-conjugated poly(lactic acid) nanoparticles encapsulating Endostar for improved in vivo anticolorectal cancer treatment[J]. INTERNATIONAL JOURNAL OF NANOMEDICINE,2015,10:3791-3802.
APA Du, Yang.,Zhang, Qian.,Jing, Lijia.,Liang, Xiaolong.,Chi, Chongwei.,...&Tian, Jie.(2015).GX1-conjugated poly(lactic acid) nanoparticles encapsulating Endostar for improved in vivo anticolorectal cancer treatment.INTERNATIONAL JOURNAL OF NANOMEDICINE,10,3791-3802.
MLA Du, Yang,et al."GX1-conjugated poly(lactic acid) nanoparticles encapsulating Endostar for improved in vivo anticolorectal cancer treatment".INTERNATIONAL JOURNAL OF NANOMEDICINE 10(2015):3791-3802.
条目包含的文件 下载所有文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
ijn-10-3791.pdf(4097KB)期刊论文作者接受稿开放获取CC BY-NC-SA浏览 下载
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Du, Yang]的文章
[Zhang, Qian]的文章
[Jing, Lijia]的文章
百度学术
百度学术中相似的文章
[Du, Yang]的文章
[Zhang, Qian]的文章
[Jing, Lijia]的文章
必应学术
必应学术中相似的文章
[Du, Yang]的文章
[Zhang, Qian]的文章
[Jing, Lijia]的文章
相关权益政策
暂无数据
收藏/分享
文件名: ijn-10-3791.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。